Drugs / TIL Product
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06961357 | Dec 2025 → May 2029 expected | melanoma | H. Lee Moffitt Cancer Center and Research Institute | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TIL Product | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06961357 ↗ |
| Modality | Cell therapy | “adoptive cell therapy” NCT06961357 ↗ |